James D. Falaschi, Maria G. Hernandez, James Potter and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
James D. Falaschi, Maria G. Hernandez, James Potter and Patricia Scates Appointed to Alameda Health System's Board of Trustees

OAKLAND, Calif., Sept. 16, 2014 (GLOBE NEWSWIRE) -- Alameda Health System (AHS) announced that James D. Falaschi, María G. Hernández, James Potter and Patricia Scates have been appointed to its Board of Trustees. Tracy Jensen has also been designated the AHS board representative from the City of Alameda Health Care District Board of Directors. Collectively, these board members provide more than 145 years worth of management experience stemming from local government, global operations, executive-level litigation, and banking.

"AHS' mission of providing world-class health care to everyone in the East Bay is tied to ongoing growth and emphasis on meeting or exceeding national standards while remaining an affordable provider of choice," said Kirk E. Miller, President of the AHS Board of Trustees. "Each of these board members brings their unique backgrounds as leaders in business and community associations to ensure that AHS is meeting its goal of providing high quality patient- and family-centered care to all."

Mr. Falaschi is a partner at Jack London Square Partners and the president of Transbay Holding Company, where he is in charge of property development for the company that owns office buildings and office parks. Additionally, he is the president of Falaschi Improvements, where he develops industrial parks and residential housing projects in Northern California and Downtown San Leandro, and is co-managing partner at Bay View Construction and Development Company that built 2,500 homes in Contra Costa and Alameda Counties.

Ms. Hernández currently serves as president of Impact4Health, a joint venture of InclusionINC and Visions, Inc., where she designed and developed The Healing Edge training initiative to improve health care team coordination, inclusive communications and collaboration for use by hospital clinical staff. She also holds the position of practice leader, global consulting services for InclusionINC, working with major clients including US Bank, ACT and Hospital Council of Central California. Her previous roles include managing director, western region of Global Novations, LLC and managing principal of MGH. She has won numerous professional honors including Outstanding Member of the Hispanic Chamber of Commerce in Contra Costa County.

Mr. Potter most recently served as the senior vice president, general counsel and secretary at Del Monte Corporation, which involved advising the board of directors regarding audit, government developments and policy matters and also acting as the company's lead negotiator on major financings, contracts, and multi-billion dollar acquisitions. While at Del Monte, he was named one of the "20 Most Influential General Counsels in America" by the National Law Journal. He has also worked for Provident Mutual Life Insurance Company as their executive vice president, general counsel and secretary of their Executive Management Committee, and as chief legal officer for Prudential Insurance Company's Prudential Banks division.

Ms. Scates was a senior vice president at Wells Fargo, where she devoted 40 years of service. During her tenure at Wells Fargo, she led diversity outreach strategies that promoted inclusion in all aspects of the company. Other roles at Wells Fargo included senior vice president and regional manager for the East Bay Regional Commercial Banking Office serving Alameda and west Contra Costa counties, which involved providing credit facilities and treasury management services to middle market and corporate companies. She is currently a member of the Oakland Metropolitan Chamber of Commerce and has served as port commissioner for the Port of Oakland and as a board member of the East Bay Economic Development Alliance for Business. Her corporate awards include the President's Award from the Urban Financial Services Coalition, among many others.

New AHS Board Representative from City of Alameda

Ms. Jensen is currently a director with the City of Alameda Health Care District Board, which oversees a $6 million parcel tax for Alameda Hospital's operations and long-term investments, and is co-chair of the District Board's Community Relations and Outreach Committee. She also works as a program analyst and senior services administrator with the City of Oakland's Department of Human Services, focused on identifying legislative and policy changes to improve services for senior residents such as the Oakland Senior Shuttle program.

About Alameda Health System (AHS)

Alameda Health System, a major public health care provider headquartered in Oakland, California, is recognized as a world-class patient and family centered system of care with more than 4,500 employees, 1,000 physicians and 480 volunteers. Their facilities include Highland Hospital, a major regional trauma center and teaching hospital; Alameda Hospital, an acute care facility providing emergency, in-patient and outpatient services in Alameda; San Leandro Hospital, which provides emergency and in-patient hospital care services; John George Psychiatric Hospital, an acute and emergency care facility in San Leandro; Fairmont Hospital, an acute rehabilitation hospital and skilled nursing facility, also in San Leandro; and four ambulatory wellness centers in Oakland as well as in Newark and Hayward.

Media contacts Jerri Applegate Randrup 510-437-4732

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 313

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 193

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 128

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 224

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 134

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 541

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 161

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Oportun Prepares for Upcoming Financial Results Announcement

Updated Category News Views 74

Upcoming Financial Results Announcement Oportun (NASDAQ: OPRT), a leader in mission-driven financial services, is gearing up for its anticipated release of third-quarter financial results. The announcement is set for Tuesday, after market hours, marking an important milestone for the company. Financial Results and Investor Insights The conference call and earnings webcast...

Continue Reading
Latest Patent Grant Marks a Milestone for Propanc Biopharma

Updated Category News Views 114

Propanc Biopharma Achieves a New Patent Milestone Propanc Biopharma, Inc. (NASDAQ: PPCB), a pioneer in biopharmaceutical innovation, has recently received a certificate of grant for its patent regarding a "proenzyme composition" from the US Patent & Trademark Office. This advancement follows the company's commitment to developing groundbreaking cancer treatments aimed at...

Continue Reading
How $100 Invested in Dell Technologies Grows Over 5 Years

Updated Category News Views 172

Understanding the Growth of Dell Technologies Dell Technologies has demonstrated remarkable resilience in the market, presenting an annualized return of 38.53% over the past five years, which is 24.26% higher than the market average. As of now, the company's market capitalization stands impressively at $73.08 billion. This strong performance reflects Dell's innovative...

Continue Reading
Osa Rooftop Lounge Opens: A Culinary Escape in Pasadena

Updated Category News Views 267

Osa Rooftop Lounge: A Culinary Haven in Pasadena Osa, a remarkable rooftop restaurant located atop the new AC Hotel Pasadena, is set to launch soon, inviting diners into a unique experience that melds delicious food, awe-inspiring views, and nature-inspired design. Nestled in Pasadena's vibrant Playhouse Village, Osa offers guests an exciting new dining destination likely...

Continue Reading
AnaptysBio: Engaging Investors at Key Conferences This November

Updated Category News Views 148

AnaptysBio's Commitment to Engagement at Investor Conferences AnaptysBio, Inc. (Nasdaq: ANAB), a pivotal player in the biotechnology sector, is dedicated to advancing immunology therapeutics aimed at treating autoimmune and inflammatory diseases. Recently, the company shared that its president and CEO, Daniel Faga, along with other senior executives, will take part in...

Continue Reading